AMGN vs UNH
AMGN: Amgen is a leading biotechnology firm dedicated to developing innovative human therapeutics to address critical unmet needs in areas like oncology, inflammation, and cardiovascular disease. UNH: UnitedHealth Group is a leading health care platform combining insurance coverage and clinical services to manage health costs and improve outcomes for millions of members.
Side-by-side fundamentals
| Metric | AMGN | UNH | Edge |
|---|---|---|---|
| Price as of 2026-08-21 close | $439.33 | $390.11 | |
| Market cap as of 2026-08-24 | $237.5B | $350.2B | |
| P/E as of 2026-08-24 | 25.84 | 25.63 | UNH lower |
| PEG as of 2026-08-24 | 5.48 | 2.39 | UNH lower |
| Net margin as of 2026-08-24 | +22.9% | +3.1% | AMGN higher |
| Gross margin as of 2026-08-24 | +74.3% | n/a | |
| Operating margin as of 2026-08-24 | +30.3% | +4.7% | AMGN higher |
| ROE as of 2026-08-24 | +89.3% | +14.4% | AMGN higher |
| ROA as of 2026-08-24 | +9.5% | +4.5% | AMGN higher |
| Debt / equity as of 2026-08-24 | 4.90 | 0.70 | UNH lower |
| Revenue growth (YoY) as of 2026-08-24 | +9.1% | +6.5% | AMGN higher |
| Revenue CAGR (3y) SEC XBRL | +11.8% | +11.4% | AMGN higher |
| Dividend yield as of 2026-08-24 | +3.2% | +1.4% | AMGN higher |
| Dividend streak (yrs) SEC XBRL | 5 | 1 | AMGN higher |
| Beta as of 2026-08-24 | 0.41 | 0.61 | |
| 1-year return as of 2026-08-21 close | +48.5% | +28.6% | AMGN higher |
Fundamentals: market data, as of 2026-08-24. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-08-21.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.